drugstr
Central, NJ
Male, 61
I have worked as a drug discovery scientist for over 30 years performing experiments to help identify novel chemical compounds for their potential in treating diseases in the areas of infection, inflammation and cardiovascular disorders. I have a good familiarity with the entire process from discovery to safety to clinical trials and even marketing. Ask me about the business of Big Pharma. I’m happy to comment on any and all hot-button issues. My opinions are quite often not pro-business.
Sorry for the late response. I believe that taste is not the major driver of appetite. In fact, dulling the senses might encourage further eating. Just my 2 cents.
Share Answer: 
I have the same questions. The answers are not very clear. The FDA has approved its use for certain rare seizure disorders and is useful in reducing nausea and vomiting in cancer chemotherapy patients. Other common claims, not formerly established indications, are chronic pain, inflammation, anxiety, appetite and several mental health conditions. Best usage - replace opiates for chronic pain. Judging effectiveness clinically has got to be difficult since therapeutic success is subjective. I imagine it's hard to identify a patient's true need versus desire for it. As far as safety goes, there are the dangers associated with intoxication and smoking probably carries risks similar to tobacco.
Share Answer: 
Thank you for bringing this to my attention. I hadn't seen this. I'm very familiar with this drug, ivermectin, IVM. It was discovered and developed in the U.S. in the 70's. Its primary use is in animal medicine for the treatment of worms in the GI tract. The Australian discovery is very exciting. They showed that IVM blocks COVID-19 in vitro (petri dish) and clinical trials are underway to test its effectiveness in humans with the disease. From what little I've read, the levels of IVM used in vitro will be difficult to achieve in the blood of patients when dosed orally, the only route of administration currently approved. Nevertheless, it may work at low levels. A successful IV safety study might be worth trying. Time will tell.
Share Answer: 
Administering convalescent plasma, or for that matter monoclonal anti-covid antibody, is referred to as passive immunity. It will no doubt be useful for patients in whom virus is circulating in the blood stream. This may well be life-saving in these patients, but it would not be expected to prevent infection which is initiated outside of the blood stream. There's more to immunity than antibodies. There's a cellular component which serves to combat invading pathogens by surveillance and direct destruction. It's not clear how important this is for disease protection or whether vaccines will generate this cellular immunity. It's possible that true immunity may only be gained by actual infection and, unfortunately, may not be permanent.
Share Answer: 
Chef
Is it true that the "specials" are usually the stuff that's been sitting around awhile?
Zookeeper and Animal Trainer
Which cuddly-seeming animals are actually dangerous to be around?
Auto Mechanic
If I know nothing about cars, how can I tell if a mechanic is ripping me off?
I would say that if these physicians' claims of success in treating COVID-19 patients are accurate then their methods should, indeed, be adopted by others. Having said that, their belief that hydroxychloroquine and azithromycin are the keys to positive outcomes is dubious. There's more to patient care than drugs. Bona fide, well-controlled clinical studies have shown these two to be of no benefit. I'm a little on the fence, however, about zinc. Zinc has a number of roles in biology. The one I'm thinking of is its interaction with protein which can influence tertiary structure (shape) and in so doing interfere with virus binding. As you probably know, zinc is purported to be a remedy for the common cold. Who knows? Maybe there's something there.
Share Answer: 
Sorry for the late response. I hope you're doing well and enjoying the program. I think that your training would prepare you well for your goal. I have seen Pharm. D.s working at all levels, but I must say that research leadership tends to be composed mainly of PhDs and MDs. Still, your success will depend entirely on your skills and ambition. Good luck!
Share Answer: 
Every drug carries risks of side-effects which are sometimes dangerous. Doctors are responsible for determining whether the curative value of a prescription outweighs these risks. A competent physician does this with full knowledge of the drug profile and an intimate knowledge of the patient’s condition. A drug manufacturer applies to the FDA for permission to market a drug for a particular indication by submitting clinical evidence proving safety and efficacy. A drug may have more than one indication in its ‘label.’ Doctors are free, however, to prescribe drugs ‘off-label’ for a condition not specifically approved by the FDA. There may be published reports to support this or the doctor may have had good results with similar agents. They do this at their peril, though. They may be liable for injury. Doctors are human and may be subject to pressure from patients, drug companies, politicians, or criminals to prescribe in a way that is not in the best interest of their patient or worse, to support the dangerous and illegal trafficking of narcotics. So to answer your question, doctors may succumb to various pressures to use their power to prescribe in ways that may cause harm, thus violating their oath.
Share Answer: 
-OR-
Login with Facebook (max 20 characters - letters, numbers, and underscores only. Note that your username is private, and you have the option to choose an alias when asking questions or hosting a Q&A.)
(A valid e-mail address is required. Your e-mail will not be shared with anyone.)
(min 5 characters)
By checking this box, you acknowledge that you have read and agree to Jobstr.com’s Terms and Privacy Policy.
-OR-
Register with Facebook(Don't worry: you'll be able to choose an alias when asking questions or hosting a Q&A.)
Browse Jobs
Host a Q&A
Search
Submit Your Question
Host a Q&A
Last 7
